Reported 1 day ago
On June 10, TSMC shares climbed by over 3% following a 40% year-over-year revenue increase in May, driven by strong AI demand. Meanwhile, Insmed's stock skyrocketed by 27% after positive results from a trial for a treatment for pulmonary arterial hypertension, marking a significant milestone for the company.
Source: YAHOO